Fexeric Den europeiske union - norsk - EMA (European Medicines Agency)

fexeric

akebia europe limited - ferrisitratkoordinasjonskompleks - hyperphosphatemia; renal dialysis - legemidler til behandling av hyperkalemi og hyperfosfatemi - fexeric er indisert for kontroll av hyperfosfatemi hos voksne pasienter med kronisk nyresykdom (ckd).

Jakavi Den europeiske union - norsk - EMA (European Medicines Agency)

jakavi

novartis europharm limited - ruxolitinib (som fosfat) - myeloproliferative disorders; polycythemia vera; graft vs host disease - antineoplastiske midler - myelofibrosis (mf)jakavi is indicated for the treatment of disease related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis. polycythaemia vera (pv)jakavi er indisert for behandling av voksne pasienter med polycythaemia vera som er resistente mot eller intolerante av hydroxyurea. graft versus host disease (gvhd)jakavi is indicated for the treatment of patients aged 12 years and older with acute graft versus host disease or chronic graft versus host disease who have inadequate response to corticosteroids or other systemic therapies (see section 5.

Nordimet Den europeiske union - norsk - EMA (European Medicines Agency)

nordimet

nordic group b.v. - methotrexate - arthritis, psoriatic; psoriasis; arthritis, juvenile rheumatoid; arthritis, rheumatoid - antineoplastiske midler - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent crohn's disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.

Alea Comp Norge - norsk - Statens legemiddelverk

alea comp

menarini international o.l. sa - olmesartanmedoksomil / amlodipinbesilat / hydroklortiazid - tablett, filmdrasjert - 20 mg / 5 mg / 12.5 mg

Alendronat Viatris 70 mg Norge - norsk - Statens legemiddelverk

alendronat viatris 70 mg

viatris limited - alendronatnatriumtrihydrat - tablett - 70 mg

Adrenalin Martindale Pharma 0.1 mg/ ml Norge - norsk - Statens legemiddelverk

adrenalin martindale pharma 0.1 mg/ ml

ethypharm (1) - adrenalintartrat - injeksjonsvæske, oppløsning - 0.1 mg/ ml

Bupivacaine Accord 5 mg/ ml Norge - norsk - Statens legemiddelverk

bupivacaine accord 5 mg/ ml

accord healthcare b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 5 mg/ ml

Bupivacaine Accord 2.5 mg/ ml Norge - norsk - Statens legemiddelverk

bupivacaine accord 2.5 mg/ ml

accord healthcare b.v. - bupivakainhydroklorid - injeksjonsvæske, oppløsning - 2.5 mg/ ml

Benetor Comp 20 mg / 12.5 mg Norge - norsk - Statens legemiddelverk

benetor comp 20 mg / 12.5 mg

menarini international o.l. s.a. - olmesartanmedoksomil / hydroklortiazid - tablett, filmdrasjert - 20 mg / 12.5 mg

Methotrexate Orion 25 mg/ ml Norge - norsk - Statens legemiddelverk

methotrexate orion 25 mg/ ml

orion corporation - espoo - metotreksat - injeksjonsvæske, oppløsning i ferdigfylt sprøyte - 25 mg/ ml